Stramsen is negotiating a potential acquisition and/or a reverse merger with several US-based publicly traded companies. HOUSTON, April 18, 2024 /PRNewswire/ — More than three years after establishment, Stramsen Biotech, Inc, is one of the leading plant-based biotech start-up companies…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.